Tim Pool @Timcast
Great news but there are more studies showing ivermectin to be effective than molnupiravir Why hasn't ivermectin been submitted for EUA? — PolitiTweet.org
Reuters @Reuters
Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study https://t.co/q6ULCMlWsH https://t.co/8NUPsOn4Qq